GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (FRA:PI3) » Definitions » Return-on-Tangible-Asset

Gubra AS (FRA:PI3) Return-on-Tangible-Asset : -6.65% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Gubra AS's annualized Net Income for the quarter that ended in Jun. 2024 was €-5.40 Mil. Gubra AS's average total tangible assets for the quarter that ended in Jun. 2024 was €81.15 Mil. Therefore, Gubra AS's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2024 was -6.65%.

The historical rank and industry rank for Gubra AS's Return-on-Tangible-Asset or its related term are showing as below:

FRA:PI3' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -10.25   Med: 4.27   Max: 27.6
Current: -7.65

During the past 5 years, Gubra AS's highest Return-on-Tangible-Asset was 27.60%. The lowest was -10.25%. And the median was 4.27%.

FRA:PI3's Return-on-Tangible-Asset is ranked better than
76.78% of 1503 companies
in the Biotechnology industry
Industry Median: -39.43 vs FRA:PI3: -7.65

Gubra AS Return-on-Tangible-Asset Historical Data

The historical data trend for Gubra AS's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Return-on-Tangible-Asset Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Asset
- 6.99 27.60 1.55 -10.24

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Return-on-Tangible-Asset Get a 7-Day Free Trial -4.59 8.74 -8.35 -8.60 -6.65

Competitive Comparison of Gubra AS's Return-on-Tangible-Asset

For the Biotechnology subindustry, Gubra AS's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Gubra AS's Return-on-Tangible-Asset falls into.



Gubra AS Return-on-Tangible-Asset Calculation

Gubra AS's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=-5.974/( (34.354+82.324)/ 2 )
=-5.974/58.339
=-10.24 %

Gubra AS's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Jun. 2024 )  (Q: Dec. 2023 )(Q: Jun. 2024 )
=-5.398/( (82.324+79.98)/ 2 )
=-5.398/81.152
=-6.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2024) net income data.


Gubra AS  (FRA:PI3) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Gubra AS Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Gubra AS's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS Business Description

Industry
Traded in Other Exchanges
Address
Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has three segments: Pre-clinical contract research (CRO), which derives maximum revenue; Discovery & Partnerships (D&P) Segment; and Gubra Green Segment.

Gubra AS Headlines

No Headlines